Tyra Biosciences (TYRA) Income Statement: Revenue & Earnings

Tyra Biosciences Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Tyra Biosciences, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00	0.00
Cost of Revenue	0.00	0.00	0.00	0.00	0.00
Gross Profit	0.00	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	80.08	62.52	43.01	20.64	7.20
Selling, General & Administrative	24.10	17.43	15.92	5.65	2.09
Operating Expenses	104.18	79.95	58.93	26.29	9.30
Operating Income	-104.18	-79.95	-58.93	-26.29	-9.30
Other Income/Expense
Interest Income	17.70	10.81	3.65	0.01	0.00
Interest Expense	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	17.70	-0.04	-0.05	-0.02	-0.04
Income
Income Before Tax	-86.48	-69.13	-55.33	-26.29	-9.34
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-86.48	-69.13	-55.33	-26.29	-9.34
Net Income - Continuous Operations	-86.48	-69.13	-55.33	-26.29	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-103.66	-79.59	-58.63	-26.15	-9.25
EBIT	-104.18	-79.95	-58.93	-26.29	-9.30
Depreciation & Amortization	0.52	0.36	0.30	0.14	0.05
Earnings Per Share
Basic EPS	-2.00	-2.00	-1.00	-2.00	-6.00
Diluted EPS	-2.00	-2.00	-1.00	-2.00	-6.00
Basic Shares Outstanding	57.22	42.70	41.88	13.78	1.54
Diluted Shares Outstanding	57.22	42.70	41.88	13.78	1.54